Determining the Prevalence and Progression of Secondary PH in Adult Patients with Sickle Cell Anemia 2018-01-08T14:28:38+00:00

CLINICAL TRIALS

December 15, 2011

Determining the Prevalence and Progression of Secondary Pulmonary Hypertension in Adult Patients with Sickle Cell Anemia

  • Study Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
  • Start Date: 2/2001
  • End Date: Closed
  • Design: Longitudinal study
  • Age range (years): 18 and older
  • Type of PH: Hem – APAH
  • Study Duration for Individual Patient (weeks): 0.14
  • Listing on clinicaltrials.gov